Current Trends in Biotechnology and Pharmacy
Open Access
SCOPUS
  • Year: 2017
  • Volume: 11
  • Issue: 2

CRISPR: Genome-Editing and Beyond

  • Author:
  • Sumiyah Rasool1, Tufail Hussain3, Asima Zehra2, Shafat Khan4, Shafqat Khan1
  • Total Page Count: 9
  • Page Number: 181 to 189

1Department of Microbiology, SKUAST-K, Srinagar, J&K, 190001, India

2Department of Public Health, SKUAST-K, Srinagar, J&K, 190001, India

3Department of Medicine, SKUAST-K, Srinagar, J&K, 190001, India

4Department of Horticultural Crop processing, SKUAST-K, Srinagar, J&K, 190001, India

Online published on 27 July, 2017.

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system has been seized upon with a fervor enjoyed previously by small interfering RNA (siRNA) and short hairpin RNA (shRNA) technologies and has enormouspotential for high-throughput functional genomics studies. Editing via (CRISPR)-CRISPRassociated (Cas) constitutes a next-generation method for programmable and high throughput functional genomics. CRISPR-Cas systems are readily reprogrammed to induce sequence-specific DNA breaks at target loci, resulting in fixed mutations via host-dependent DNA repair mechanisms. Bacteria and archaea acquire resistance to invading viruses and plasmidsby integrating short fragments offoreign nucleic acids at one end of the CRISPR locus. CRISPR loci are transcribedand the long primary CRISPR transcript is processed into a library of small RNAs that guide the immune system to invading nucleic acids, whichare subsequently degraded by dedicated nucleases.

Keywords

CRISPR, bacterial immunity, gene editing